CIK 0001641489 · Non-accelerated filer<br>Smaller reporting company
vTv Therapeutics Inc.
Sign in to watch- Ticker
- VTVT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473916571
- Phone
- 336-841-0300
- Business address
- 3980 PREMIER DR, SUITE 310, HIGH POINT, NC, 27265
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-13 | Phillips Anne M. Director | Grant or award · Director stock option (right to buy) | +3,750 | $16.04 | $60K | 3,750 |
| 2024-03-05 | Samsara BioCapital GP, LLC 10% owner | Other disposition | −58,836 | 206,784 | ||
| 2024-03-05 | Samsara BioCapital GP, LLC 10% owner | Grant or award · Pre- Funded Warrants (Right to Buy) | +58,885 | 892,578 | ||
| 2024-03-05 | AKKARAJU SRINIVAS Director | Returned to the company | −58,836 | 206,784 | ||
| 2024-03-05 | AKKARAJU SRINIVAS Director | Grant or award · Pre- Funded Warrants (Right to Buy) | +58,885 | 892,578 | ||
| 2024-03-05 | BAKER BROS. ADVISORS LP Director | Returned to the company | −4,776 | 8,060 | ||
| 2024-03-05 | BAKER BROS. ADVISORS LP Director | Returned to the company | −52,881 | 89,254 | ||
| 2024-03-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +4,780 | 254,948 | ||
| 2024-03-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Prefunded Warrants | +52,925 | 2,823,061 | ||
| 2024-02-27 | Al-Marzooqi Fahed Director | Grant or award · Director stock option (right to buy) | +4,055 | $11.81 | $48K | 6,555 |
| 2024-02-27 | SEKHRI PAUL J President and CEO | Grant or award · Employee stock option (right to buy) | +89,212 | $11.81 | $1.1M | 144,212 |
| 2024-02-27 | Tuch Steven L. Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +62,159 | $11.81 | $734K | 74,659 |
| 2024-02-27 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (Right to Buy) | +3,750 | 3,750 | ||
| 2024-02-27 | AKKARAJU SRINIVAS Director | Grant or award | +224,732 | $11.81 | $2.7M | 265,620 |
| 2024-02-27 | AKKARAJU SRINIVAS Director | Grant or award · Pre- Funded Warrants (Right to Buy) | +833,693 | $11.80 | $9.8M | 833,693 |
| 2023-06-19 | FRY JOHN A Director | Grant or award · Director stock option (right to buy) | +75,000 | 75,000 | ||
| 2023-06-19 | Al-Marzooqi Fahed Director | Grant or award · Director stock option (right to buy) | +75,000 | 75,000 | ||
| 2023-06-19 | Harjivan Chandresh Director | Grant or award · Director stock option (right to buy) | +75,000 | 75,000 | ||
| 2023-06-19 | Harris Keith R. Director | Grant or award · Director stock option (right to buy) | +75,000 | 75,000 | ||
| 2023-06-19 | Weiner Howard L. Director | Grant or award · Director stock option (right to buy) | +75,000 | 75,000 |
Page 3 of 13 · 256 trades